Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;55(4):105946.
doi: 10.1016/j.ijantimicag.2020.105946. Epub 2020 Mar 19.

Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status

Affiliations

Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status

Chih-Cheng Lai et al. Int J Antimicrob Agents. 2020 Apr.

Abstract

It has been 2 months since the first case of coronavirus disease 2019 (COVID-19) was reported in Wuhan, China. So far, COVID-19 has affected 85 403 patients in 57 countries/territories and has caused 2924 deaths in 9 countries. However, epidemiological data differ between countries. Although China had higher morbidity and mortality than other sites, the number of new daily cases in China has been lower than outside of China since 26 February 2020. The incidence ranged from 61.44 per 1 000 000 people in the Republic of Korea to 0.0002 per 1 000 000 people in India. The daily cumulative index (DCI) of COVID-19 (cumulative cases/no. of days between the first reported case and 29 February 2020) was greatest in China (1320.85), followed by the Republic of Korea (78.78), Iran (43.11) and Italy (30.62). However, the DCIs in other countries/territories were <10 per day. Several effective measures including restricting travel from China, controlling the distribution of masks, extensive investigation of COVID-19 spread, and once-daily press conferences by the government to inform and educate people were aggressively conducted in Taiwan. This is probably the reason why there was only 39 cases (as of 29 February 2020) with a DCI of 1 case per day in Taiwan, which is much lower than that of nearby countries such as the Republic of Korea and Japan. In addition, the incidence and mortality were correlated with the DCI. However, further study and continued monitoring are needed to better understand the underlying mechanism of COVID-19.

Keywords: COVID-19; Coronavirus disease 2019; Country healthcare resources; Daily cumulative index; Disease incidence; Mortality.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Daily cumulative case number of patients with coronavirus disease 2019 (COVID-19) in five main geographical regions and the international conveyance (Diamond Princess cruise ship) as of 29 February 2020.
Fig 2
Fig. 2
Daily cumulative case number of patients with coronavirus disease 2019 (COVID-19) in four different categories of countries according to number of reported cases as of 29 February 2020: (A) ≥100 reported cases; (B) 50–99 reported cases; (C) 20–49 reported cases; and (D) 10–19 reported cases. Inverted triangles with different colours denote the date of the first reported case in each indicated country.
Fig 2
Fig. 2
Daily cumulative case number of patients with coronavirus disease 2019 (COVID-19) in four different categories of countries according to number of reported cases as of 29 February 2020: (A) ≥100 reported cases; (B) 50–99 reported cases; (C) 20–49 reported cases; and (D) 10–19 reported cases. Inverted triangles with different colours denote the date of the first reported case in each indicated country.
Fig 3
Fig. 3
(A) Epidemic curve (‘epicurve’) of the 39 patients with coronavirus disease 2019 (COVID-19) and implementation of primary control measures in Taiwan from 21 January to 29 February 2020. (B) Geographical distribution of the 39 patients with COVID-19 and (C) the possible modes of transmission [https://www.cna.com.tw/news/ahel/202003010211.aspx; accessed 2 March 2020]. * Taiwanese businesswoman returning from China who had negative real-time RT-PCR for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the respiratory tract but positive anti-SARS-CoV-2 antibody in the serum.
Fig 4
Fig. 4
Incidence (per 1 000 000 population), mortality rate (%) and deaths per 1 000 000 population of patients with coronavirus disease 2019 (COVID-19) and their association (Spearman's rank-order correlation) with (A) daily cumulative index (DCI), (B) Health Care Index (HCI) and (C) Healthcare Access Quality Index (HAQI) by country.

Similar articles

Cited by

References

    1. World Health Organization (WHO) WHO; Geneva, Switzerland: 2020. Coronavirus disease 2019 (COVD-19). Situation report – 40.https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... Data as reported by 10AM CET 29 February 2020. [accessed 17 March 2020]
    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28 doi: 10.1056/NEJMoa2002032. [Epub ahead of print] - DOI - PMC - PubMed
    1. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55 doi: 10.1016/j.ijantimicag.2020.105924. - DOI - PMC - PubMed
    1. Lai C.C., Liu Y.H., Wang C.Y., Wang Y.H., Hsueh S.C., Yen M.Y. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect. 2020 March 4 doi: 10.1016/j.jmii.2020.02.012. - DOI - PMC - PubMed
    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24 doi: 10.1001/jama.2020.2648. [Epub ahead of print] - DOI - PubMed

MeSH terms